# Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia

> **NCT04652479** · PHASE2 · COMPLETED · sponsor: **Dr. Tracey McLaughlin, MD** · enrollment: 25 (actual)

## Conditions studied

- Acquired Hyperinsulinemic Hypoglycemia

## Interventions

- **DRUG:** Avexitide

## Key facts

- **NCT ID:** NCT04652479
- **Lead sponsor:** Dr. Tracey McLaughlin, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-21
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04652479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04652479, "Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04652479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*